Ingredients: MILK THISTLE SEEDS, DANDELION, BOLDO, ARTICHOKE, BARBERRY, TURMERIC, GENTIAN ROOT, BUPLEUREM, OREGON GRAPE, QUASSIA, TOADFLAX, BLUE FLAG, FRINGETREE, PEONY ROOT, CELADINE, MANDRAKE, CHICORY, LIVERWORT, FUMITORY, AGRIMONY, WAHOO BARK, FENUGREEK, MANJISTHA, CHANCA PIEDRA AND GOLDENSEAL.
Directions: Take three (3) capsules daily. Take consistently for optimum benefit.
*100 vegetarian capsules per bottle.
FACTS: The liver is the largest internal organ in the human body and performs over 500 different functions.
About 1.25 million Americans are estimated to be chronically infected with hepatitis B. Of these people, 20 to 30 percent acquired their infection in childhood.
The overall rate of death from a hepatitis B infection is 1 percent.
Acute Hepatitis B will lead to a chronic (long-term) liver infection in 30 percent to 90 percent of people infected as infants or children and 6 to 10 percent of people who are infected as adolescents and adults. Chronic infection can lead to chronic liver disease, liver scarring (cirrhosis), and liver cancer.
Health experts estimate 180 million people have chronic hepatitis C worldwide. The hepatitis C virus was not discovered until 1989. A test to detect the virus in the blood was not developed until 1992.
Hepatitis C infection is the most common chronic blood borne infection in the U.S. Approximately 4.1 million persons, or 1.6% of the total U.S. population, are infected with hepatitis C.
Of persons infected with hepatitis C, 85% will remain infected for life; of those:
60 - 70% will develop chronic liver disease
10 - 20% will develop cirrhosis (scarring of the liver)
1 - 5% will develop liver cancer
Liver failure from chronic hepatitis C is one of the most common reasons for liver transplants.
In 2005, about 6,500 liver transplants were performed in the U.S.
The number of liver transplants performed per year has been increasing steadily for more than 15 years.
Chronic liver disease is the tenth leading cause of death among adults in the U.S., causing approximately 25,000 deaths annually.
40% of deaths from chronic liver disease can be attributed to hepatitis C.
The Centers for Disease Control and Prevention predicts that deaths due to hepatitis C will double or triple in the next 15 to 20 years.
From year 2010 through 2019, direct medical costs of HCV-related liver disease are projected to reach $10.7 billion. - Arizona Department of Health Services
The above statements have not been approved by the FDA and the product is not intended to treat, cure, prevent, or mitigate any disease.
Write Your Own Review
Only registered users can write reviews. Please, log in or register